$0.89
$0.08 (+10.02%)
$0.81Day Range$0.89
Key Statistics
Market Cap
$10.48M
Shares Outstanding
11.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 14, 2023
Round Lot
100
Locale
US
Trading Data
Day Open
$0.86
Day High
$0.89
Day Low
$0.81
Volume
4.3K
VWAP
$0.87
Prev Close
$0.81
Transactions
--
Acc. Volume
--
About CytoMed Therapeutics Limited Ordinary Shares
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Identifiers
- CIK
- 0001873093
- Ticker Root
- GDTC
About CytoMed Therapeutics Limited Ordinary Shares (GDTC) Stock
CytoMed Therapeutics Limited Ordinary Shares (GDTC) closed the 2026-09-16 session at $0.89, up 10.02% versus the previous close (+0.08). The stock opened at $0.86 and traded between $0.81 and $0.89 during that session. Session trading volume was 4K shares. The volume-weighted average price (VWAP) is $0.87.
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
CytoMed Therapeutics Limited Ordinary Shares has a market capitalization of $10.5 million. GDTC is listed on the XNAS exchange. The company employs approximately 42 people. The recorded listing date is 2023-04-14.
On this page you can find market GDTC stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.